PCT LTD Deploys Initial Annihilyzer(R) Infection Control System to the United Kingdom

Little River, South Carolina--(Newsfile Corp. - October 22, 2019) - PCT LTD (OTC Pink: PCTL), a Little River, South Carolina company and the designer of the Annihilyzer® Infection Control System, a world class whole room cleaning and disinfecting system for hospitals and health care facilities, is pleased to announce that it has shipped the first overseas Annihilyzer® Infection Control System to its partner company, PCT Europe Ltd., in the United Kingdom.

The phase one installation will begin in November at a large 500 bed hospital in England. Upon successful completion of this initial installation, a continuing flow of orders from associated UK hospitals is expected during 2020.

Addressing and reducing the high number of HAI's (hospital associated infections) in British hospitals is a current and continuing priority of the United Kingdom's government. The incidence of HAI's in the U.K. and Europe is as serious as it is in the United States, costing health care providers an average of $30,000 per case.

PCT Ltd is confident that its first export of the Annihilyzer® Infection Control System to the U.K. will be successful, in the same way its installations in six well known United States hospitals have resulted in a significant reduction of in the number of HAI's within these facilities.

About PCT LTD:

PCT LTD ("PCTL") focuses its business on acquiring, developing and providing sustainable, environmentally safe disinfecting and tracking technologies products. The company acquires and holds rights to innovative products and technologies, which are commercialized through its wholly-owned operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp). Currently trading on OTC, "PCTL" aspires to and is actively engaged in preparations for up-listing its common stock to a national securities exchange. The Company established entry into its target markets with commercially viable products in the United States and now continues to gain market share in the U.S. and U.K.

Forward-Looking Statements

This press release contains "forward-looking statements" as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21B of the Securities Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward-looking statements." Such statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Such statements involve risks and uncertainties, including but not limited to: any implied or perceived benefits resulting from the continued positive results relating to the installation of PCT's Annihilyzer® systems in hospitals; the results of any manufacturers' representative and/or license agreements, actual sales revenue to be derived from agreements, if any such contract is executed; PCT LTD's and its subsidiary's business prospects; PCT LTD's ability to raise sufficient funds to satisfy its working capital requirements; the ability of PCT LTD to execute its business plan or list its common stock on a national stock exchange; benefits of the Annihilyzer® Infection Control Systems, Hydrolyte® generators and fluids; any other effects resulting from the information disclosed above; risks and effects of legal and administrative proceedings and government regulation; future financial and operational results; competition; general economic conditions; and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements PCT LTD makes in this press release include market conditions and those set forth in reports or documents it files from time to time with the United States Securities Exchange Commission. PCT LTD undertakes no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Contacts

Company:
Gary Grieco, President and Chairman of the Board
(843) 390-7900 Office
(843) 390-2347 Fax
www.para-con.com
www.pcthealth.com
www.survivalyte.com

Investor Relations:
Chesapeake Group
305 Washington Avenue, Suite 100
Towson, MD 21204
(410) 825-3930
www.chesapeakegp.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/49007

info